A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
Clinical trial NCT03771586 · COMPLETED
Trial details
- NCT number
- NCT03771586
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2018-12-17
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.